This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting central nervous system disorders, such as anxiety and depression, due to its structural properties that allow for effective interaction with specific receptors in the brain. Additionally, it is employed in the development of compounds with potential anti-inflammatory and analgesic properties, making it valuable in the creation of medications for pain management. Its trifluoromethyl group enhances its metabolic stability and bioavailability, which is crucial for improving the efficacy of therapeutic agents. Researchers also explore its use in the design of novel molecules for treating neurodegenerative diseases, leveraging its ability to cross the blood-brain barrier.